Abstract
AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Current Drug Therapy
Title: Use and Results of Antidepressant Treatment: Patients' Perception
Volume: 6 Issue: 4
Author(s): Maria-Jose Martin-Vazquez, Mauro Garcia-Toro, Francisco Campoamor, Antonio Pareja, Iratxe Aguirre, Joan Salva and Miquel Roca
Affiliation:
Keywords: Adherence, antidepressant, antidepressant indication, compliance, patients' perception, treatment response, use of treatment, Venlafaxine, hypochondriac depressive symptoms
Abstract: AIMS AND METHOD: Response to antidepressants depends on patients' use. Our objective is to take a look over antidepressants use in a real sample. In determining relevant factors, data were gathered from 550 patients, currently taking antidepressants. The questionnaire included two items, patients' perceived difficulty of following treatment and level of acknowledged non-compliance, which may be considered as a way of approximating the patients' real use of treatment. RESULTS: compliance was poor among the less educated, living in rural areas and receiving concomitant treatment. Use perceived as good in 61.5%, better in affective disorder (69.8%). Patients without response present higher incidence of non-compliance (49.1%). It should be mandatory to explore and reinforce a good use of antidepressants in clinical settings, particularly if the indication is not an affective disorder and in case of multiple treatments, rural setting, and lower educational level. If response is inadequate, compliance must be revised specially.
Export Options
About this article
Cite this article as:
Martin-Vazquez Maria-Jose, Garcia-Toro Mauro, Campoamor Francisco, Pareja Antonio, Aguirre Iratxe, Salva Joan and Roca Miquel, Use and Results of Antidepressant Treatment: Patients' Perception, Current Drug Therapy 2011; 6(4) . https://dx.doi.org/10.2174/157488511798109619
DOI https://dx.doi.org/10.2174/157488511798109619 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Autoantibodies Associated with Psychiatric Disorders
Current Neurovascular Research Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge)
Current Vascular Pharmacology Perforated One Anastomosis Gastric Bypass, How we Managed and Review of Literature
New Emirates Medical Journal Poly(Ethylene Glycol)-block-Poly(ε-Caprolactone) Nanomicelles for the Solubilization and Enhancement of Antifungal Activity of Sertaconazole
Current Drug Delivery Considerations in the Pharmacotherapy of Bipolar Disorder During and After Pregnancy
Current Drug Safety Microvascular Alterations in Hypertension and Vascular Aging
Current Hypertension Reviews Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects
Current Medicinal Chemistry Tetralogy of Fallot and Hypoplastic Left Heart Syndrome – Complex Clinical Phenotypes Meet Complex Genetic Networks
Current Genomics Development of Controlled Release Osmotic Pump Tablet of Glipizide Solid Dispersion
Current Drug Delivery Modulation of Plasma Non Enzimatic Antioxidant Capacity (NEAC) by Plant Foods: the Role of Polyphenol
Current Topics in Medicinal Chemistry Maternal Nutrition and Predisposition to Later Kidney Disease
Current Drug Targets COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region
Current Diabetes Reviews Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Application of Aptamer-based Hybrid Molecules in Early Diagnosis and Treatment of Diabetes Mellitus: From the Concepts Towards the Future
Current Diabetes Reviews Type 2 Diabetes Mellitus and the Elderly: An Update on Drugs Used to Treat Glycaemia
Current Vascular Pharmacology Targeting the Liver in the Metabolic Syndrome: Evidence from Animal Models
Current Pharmaceutical Design Editorial [Hot Topic: Novel Peptides and Proteins in Diabetes Mellitus (Guest Editors: Po Sing Leung and Marc de Gasparo)]
Current Protein & Peptide Science Cytokine-Induced Inflammatory Liver Injuries
Current Molecular Medicine Diagnostic Tools for Diabetic Sensorimotor Polyneuropathy
Current Diabetes Reviews Therapeutic Approach on AGE-RAGE Interaction and Its Function in Diabetic Inflammation Process
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery